Vical Reports Impressive Trial Results
Vical Inc. (VICL) reported impressive results for its gene delivery technology sending the stock price soaring 96 cents to close at $5.95.
posted by FC Market News at 10:39 AM
Monday, June 18, 2007
Previous Posts
- Infinera To Provide Equipment To ITC Deltacom
- Build-A-Bear Lowers Forecast
- Progressive Downgraded
- Revenue Falls For Alliance One
- Expedia Rumored To Go Private
- Penn National Gaming To Go Private
- Luna Licenses Technology To Intuitive
- Hoku Signs $678 Million Deal With Suntech
- FDA Rejects Sanofi-Aventis' Drug
- Sun Reaffirms Growth Targets
0 Comments:
Post a Comment
<< Home